Dose-response relationship for mydriasis produced by topical ocular tyramine in man.
M. Peet,R. Yates,A. G. Shields
DOI: https://doi.org/10.1111/J.1365-2125.1980.TB04804.X
British Journal of Clinical Pharmacology
Abstract:Tyramine is an indirectly acting sympathomimetic amine which is actively transported into sympathetic nerve terminals from which it causes the release of noradrenaline. Tyramine eyedrops thus cause dilatation of the pupil. The mydriatic response to tyramine is modified by drugs which act at the sympathetic neuro-effector junction, and this has provided a useful technique in the investigation of such drugs as tricyclic antidepressants (Ghose, 1976; Szabadi, Besson & Bradshaw, 1975) monoamine oxidase inhibitors (Bevan-Jones & Lind, 1971) and guanethidine (Sneddon & Turner, 1969). In published studies, tyramine has generally been administered from a standard eye-dropper. Such droppers deliver a volume of 50-75 il, much of which overflows from the conjunctival sac which holds a maximum of 30 gl (Chrai, Patton, Mehta & Robinson 1973). The administration of such large volumes ensures that the immediate concentration of drug in the tear film will closely approximate that of the instilled solution (Chrai, Makoid, Erikson & Robinson, 1974). However, this is not an acceptable way of delivering a known absolute dose of tyramine. Little attention has been paid to dose-response relationships for tyramine eyedrops, although in one study (Palm, Fengler, Gullner, Planz, Quiring, May, Hehnstaedt, Lemmer, Moon & Holler, 1970) there was a clear difference in pupillary effect between 120 Mg and 500 jg of tyramine. Reduction of the instilled volume facilitates accurate dosing and increases ocular bio-availability of a given dose of drug (Patton & Francoeur, 1977), thus enabling detailed investigation of the dose-response relationship. Subjects for the present investigation were six healthy blue-eyed Caucasian male volunteers aged 27-37 years. A commercially available 2.5% solution of tyramine ('Mydrial', Winzer, Germany) was used undiluted as well as in 10 x and 100 x dilutions in water. Each volunteer was given a 5 Ml and a 15 pi dose ofeach solution of tyramine. Thus, six doses were used: 1.25 pg, 4.75 Mg 12.5 Mg, 47.5 jg, 125 Mg, and 475 Mg. Subjects were dosed twice weekly with a minimum of 48 h between doses. The six doses were given in ascending order. In three subjects a seventh dose was given, this being a repetition of a dose (47.5 pg) from the middle of the dose range studied. Each dose was given onto the right conjunctiva using a 'Pipetman' P20 automatic micropipette with a sterilised disposable tip. On each study day the volunteer's eyes were photographed using a camera attached to a headframe which also carried twin flash lamps. Background illumination was constant artificial light. Photographs were taken before dosing, every 15 min for the first hour after dosing, every 30 min for 2 h